Abstract
Introduction
Stroke is the leading cause of death and serious, long-term disability. To date, clinical strategies that help to stop the neurodegeneration following anoxic/ischemic insults remain limited. [(D-Ala2, D-Leu5) enkephalin] (DADLE) is a synthetic opioid peptide and a highly selective delta opioid receptor (DOR) agonist [1, 2] . Since the neuroprotective effects of DOR [1] , it has attracted a great deal of attention from researchers worldwide. Accumulating evidence has suggested that stimulating DOR with DADLE elicits potent neuroprotection against anoxic/ischemic injury [1, [3] [4] [5] . Therefore, DADLE may be a promising novel therapeutic candidate for treating neurodegeneration in stroke.
After the neuroprotective effects of DOR activation were recognized, subsequent studies focused on the underlying mechanism of DORs, and great progress has been made so far. The DOR is a G i protein-coupled receptor that functions through the cAMP signaling pathway [6] . Although the details remain unclear, it is generally accepted that the mechanisms of DOR neuroprotection fall into two categories: DORs can trigger endogenous protective pathways [4, [7] [8] [9] and maintain ionic homeostasis [10] [11] [12] [13] tiple studies that the PKC/MAPK pathway plays a crucial role in the neuroprotective functions of DORs [4, 7, 8, 14] . Moreover, DOR activation might elicit neuroprotection via the PI3K/Akt signaling pathway [15, 16] . Our previous studies have investigated the neuroprotective effects of DADLE using a NaN 3 -induced mitochondrial dysfunction model. Much to our surprise, we found that stimulating DOR with DADLE for both a short (minutes) and long (days) time showed notable protective effects on pri-mary rat cortical neuronal cultures [8, 17] . Further investigation revealed that short-term DADLE stimulation increases neuronal survival through the PKC-mitochondrial ERK pathway in the NaN 3 model [8] . However, the mechanism underlying the protective effects of DADLE during prolonged exposure remains unclear. In this study, we will explore the possible downstream signaling pathways mediating the neuroprotective effects of sustained DOR stimulation with DADLE in the NaN 3 -induced neuronal injury model.
Materials and methods
Primary culture of rat cortical neurons Primary cortical neuron cultures were prepared as previously described [8, 17] d17-18; Shanghai Experimental Animal Center, Chinese Acadthe cells were resuspended in neurobasal medium (Gibco-BRL, Life Technologies, Rockville, MD, USA) supplemented with B-27, glutamine (0.5 mmol/L), penicillin (100 U/mL) and L-lysine (100 -sity of 1×10 6 cells/mL. The cells were ready for drug administration on day 8. Animal experiment protocols complied with the guidelines of the Animal Care and Use Committee of Fudan University. All efforts were made to minimize the suffering of the animals.
Drug administration
Freshly prepared NaN 3 cultured neurons to induce mitochondrial dysfunction. administered to selectively activate or inhibit DOR activity [8, 17] . [18] . All drugs were purchased from Sigma (St Louis, MO, USA).
Lactate dehydrogenase (LDH) assay
The activities of LDH in the cultivated medium were measured with an LDH kit (Sigma, St Louis, MO, USA) and detected with a DU-640 spectrophotometer (Beckman Instruments, Inc., Fullerton, CA, USA) as previously described [8, 17] . The absorbance data were normalized to those of the control group.
Cell viability assay
Cell viability assays were performed by adding cell counting kit-8 reagent (CCK-8, Dojindo Laboratories, Japan) directly to the cell cultures. After incubation at 37 °C for 1 h, the absorbance was read by a spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) at a wavelength of 450 nm and was proportional to the number of living cells. Each experiment was repeated three times.
Cytosolic and nuclear protein preparation Cytosolic and nuclear proteins were extracted using a nuclear extraction kit (Chemicon, Temecula, CA, USA) according to after drug exposure and incubated in cytoplasmic lysis buffer for 15 min. The cells were pelleted by centrifugation at 250×g for 5 min and resuspended in cytoplasmic lysis buffer. A syringe with a small gauge needle was used to break up the cytoplasmic membrane. The supernatant was collected after centrifugation at 8000×g for 20 min and used as the cytosolic fraction. The remaining nuclear pellet was resuspended in nuclear extraction buffer for 30 min, and a fresh syringe was used to disrupt the nuclei. Following centrifugation at 16 000×g for 5 min, the supernatant was collected and used as the nuclear extract. Each step was performed on ice at 4 °C.
Immunoblotting analyses
Neurons were harvested after drug exposure, and the cell lysates were prepared as described before [8] . Protein samples antibodies used were as follows: rabbit polyclonal antibodies against pp38, p38, pERK, ERK, pJNK, JNK, pAkt, Akt, and H3 (1:1000; all from Cell Signaling Technology, Danvers, MA, USA), rabbit antibodies against pp85, p85, p65, and Bcl-2 (1:1000; all from Chemicon, Temecula, CA, USA), mouse antisheep antibody against Cyto c (1:1000; Chemicon, Temecula, CA, USA).
RNA extraction, RT-PCR and real-time PCR
T o t a l R N A w a s e x t r a c t e d b y u s i n g T r i z o l r e a g e n t ( I n v i t r o g e n , C a r l s b a d , C A , U S A ) a c c o r d i n g t o t h e transcribed by using the PrimeScript RT reagent kit (Takara, Japan), and single stranded cDNA was amplified by quantitative real-time PCR with the SYBR Premix Ex Taq Kit (Takara, Japan) on a Mastercycler ep realplex realtime PCR system (Eppendorf, Hamburg, Germany). The ) with GAPDH as the internal control. The following primers were used: Bcl-2, 5'-CCCTGTGGATGACTGAGTAC-3' and 5'-GCATGTTGACTTCACTTGTG-3'; GAPDH, 5'-CCA-CTCCTCCACCTTTGAC-3' and 5'-ACCCTGT TGCTGT-AGCCA-3'. Data are presented as the means±SEM of 4 independent experiments with 3 real-time PCR replicates.
Chromatin immunoprecipitation (ChIP) assay
ChIP assays were performed using a ChIP assay kit (Millipore, Billerica, MA, USA) according to the manufacturer's protocol. In brief, after drug treatment, neuronal cells were cross-linked with formaldehyde, lysed and sonicated. ImmuSignaling Technology, Danvers, MA, USA), acetyl-H3 and acetyl-H4 (both from Chemicon, Temecula, CA, USA). Additionally, samples were immunoprecipitated with rabbit IgG as a negative control. Immunoprecipitated DNA was subjected to semi-quantitative and quantitative real-time PCR analyses using primers specific for the Bcl-2 promoter (5'-TGTA-ACTTTCAATGGACGC-3' and 5'-ATCTACTTCCTCCGproduct was analyzed on 2% agarose gels. Real-time PCR was performed as described above.
Statistical analysis
The data are shown as the mean±SEM and were subjected to statistical analysis using one-way ANOVA. The level of statis-P<0.05.
Results
Prolonged DADLE exposure selectively activates the PI3K/Akt/ 3 -treated neurons To examine the influence of prolonged DADLE stimulation on MAPK and Akt activity in NaN 3 -treated neurons, primary NaN 3 and DADLE or NTI for 2 d. The phosphorylation levels and the total levels of ERK, JNK, p38 and Akt were detected by immunoblotting after drug treatment. Neither the phosphorylation levels nor the total levels of ERK, p38 or JNK were affected by NaN 3 ( Figure 1A) ; however, the levels of pAkt were reduced by NaN 3 (0.4-fold higher than those of the controls), and the total Akt levels were not affected ( Figure 1C ). DADLE not only reversed the NaN 3 -induced inhibition of Akt activation but also further increased the levels of pAkt (1.72-fold higher than those of the controls); these effects were abolished by NTI ( Figure 1C) .
Next, the phosphorylation levels and total levels of the p85 subunit of PI3K were determined by immunoblotting after drug treatment. As shown in Figure 1B , the levels of pp85 were significantly decreased by NaN 3 , and DADLE not only reversed the NaN 3 -induced decrease in pp85 levels but also further elevated PI3K activity; these effects were abolished by NTI. Moreover, the total levels of p85 were not altered in any group after drug exposure. LY296004, a selective PI3K inhibitor, also prevented Akt activation in the neurons exposed to DADLE and NaN 3 ( Figure 1C ), indicating that PI3K acts as a downstream signal of DOR stimulation and is required for Akt activation in NaN 3 -treated neurons.
To explore the impact of sustained DADLE stimulation on 3 -treated neurons, translocation by immunoblotting after drug exposure. The levels of p65 in the nucleus were remarkably decreased by NaN 3 , and this effect was attenuated by DADLE. The effect of DADLE was abolished by NTI, LY296004 and Akt inhibitor VIII, implying that DOR stimulation reverses NaN 3 via the PI3K/Akt pathway. The data above suggest that sustained DOR stimulation with but not MAPKs in the NaN 3 model.
Prolonged DADLE treatment reduces cell injury in NaN 3 -treated neurons via the PI3K/Akt pathway To determine whether the protective effect of sustained DADLE stimulation is mediated by the PI3K/Akt pathway, neuronal damage was determined by measuring LDH release into the culture medium after drug exposure, and cell viability was detected by using a CCK-8 kit. DADLE completely suppressed the increase in LDH release induced by NaN 3 and restored cell viability; these effects were abolished by LY296004 and VIII (Figure 2 ). These data imply that sustained DOR stimulation reduces NaN 3 -induced neuronal injury via the PI3K/Akt pathway.
attenuates Cyto c release in NaN 3 -treated neurons through the PI3K/Akt pathway NaN 3 mitochondrial dysfunction and Cyto c release [19, 20] . To explore the effect of sustained DADLE stimulation on mitochondrial Cyto c release in NaN 3 -treated neurons, the levels of cytosolic Cyto c were tested by immunoblotting after drug exposure. As seen in Figure 3A , Cyto c levels in the cytosolic fraction were robustly increased by NaN 3 ; this effect was suppressed by DADLE. The effect of DADLE was totally abolished by NTI, LY296004 and VIII, implying that sustained DOR stimulation in NaN 3 -treated neurons prevents Cyto c release through the PI3K/Akt pathway.
Bcl-2 is a well-known anti-apoptosis protein that prevents Cyto c release [21] . To investigate the impact of sustained DOR activation on Bcl-2 expression in NaN 3 -exposed neurons, Bcl-2 levels were determined by immunoblotting after drug exposure. As shown in Figure 3B , Bcl-2 levels were considerably reduced by NaN 3 , and this effect was reversed by DADLE; furthermore, the effect of DADLE was entirely prevented by NTI, LY296004 and VIII. Next, the mRNA levels of Bcl-2 were determined after drug treatment. Bcl-2 mRNA levels were significantly decreased by NaN 3 ; this effect was reversed by DADLE ( Figure 3C) . Again, the effect of DADLE was completely inhibited by NTI, LY296004 and VIII, indicating that sustained DOR stimulation with DADLE in NaN 3 -treated neurons restores Bcl-2 protein levels by attenuating its transcriptional dysfunction via the PI3K/Akt pathway.
These results indicate that sustained DOR stimulation with DADLE decreases cell damage in NaN 3 -treated neurons by promoting Bcl-2 expression and preventing Cyto c release through the PI3K/Akt pathway.
binding activity and histone acetylation of the Bcl-2 promoter in neurons treated with NaN 3 -ity of Bcl-2 [22] ; therefore, we further investigated whether the during sustained DOR activation. According to ChIP assays, Bcl-2 promoter were remarkably reduced by NaN 3 ; this effect was completely blocked by DADLE (Figure 4 ). The effect of DADLE was abolished by NTI, which indicates that sustained Bcl-2 promoter in NaN 3 -treated neurons. ChIP was also used to determine the effect of DADLE on the histone acetylation level of the Bcl-2 promoter in NaN 3 -treated neurons. As shown in Figure 5 , the levels of acetylated H3 and H4 for the Bcl-2 promoter were both remarkably reduced by NaN 3 ; these effects were completely blocked by DADLE. The effects of DADLE were abolished by NTI. These data suggest that sustained DOR activation increased the histone acetylation levels of the Bcl-2 promoter in neurons treated with NaN 3 . 
Discussion
So far, there are no effective treatments to stop or reverse neurodegeneration after a stroke. Despite the encouraging results seen in preclinical studies, most cytoprotective drugs have failed in clinical trials. One of the main reasons for this is that those drugs showed protection at only the very early stage of neurodegeneration, and their effects did not last as the disease developed. Our earlier work found that stimulating DOR with DADLE for both a short (minutes) and long (days) time resulted in sig-3 model [8, 17] . These results imply that DADLE provides immediate protection at the early stage of neuronal injury and that its protective effects would last for days if the toxin is not removed. Our further investigations of the underlying mechanisms revealed that at least two downstream signaling pathways may be sequentially activated and responsible for the neuroprotective effects of DADLE against mitochondrial injury. While short-term DADLE stimulation increases neuronal survival through the PKC-mitochondrial ERK pathway [8] , sustained DOR activation with DADLE in the present study had little effect on MAPK activity in NaN 3 -treated neurons but selectively activated the neuroprotective effects of prolonged DOR activation.
Though the intricacies of the role of DOR in neuroprotection
are not yet well-established, several endogenous neuroprotective pathways have been reported to be involved. Activating DOR via hypoxia preconditioning can balance the pERK and pp38 levels through the PKC/MAPK pathway; this action elicits neuroprotective effects in a severe hypoxia model in vitro [4] . Narita et al found that the neurogenesis and anti-apoptosis * P ** P # P effects of DOR stimulation may rely on Trk phosphorylation, which is associated with PI3K, MEK, and CaMKII activation in normally cultured neural stem cells and in H 2 O 2 -treated cells [23] . DOR activation also protects NG108-15 cells from pertussis toxin insult through activating the PI3K/Akt signaling pathway [15] . This evidence further indicates that DOR activation causes potent neuroprotection through distinct pathways, which makes DOR a potential therapeutic target.
The role of DOR in neuronal transcription and gene expression has not been well studied until recently. It has been reported that DADLE induces transcription inhibition, especially in apoptotic pathways, which may result in cellular metabolism arrest and provide neuroprotective effects [24, 25] . Nevertheless, this effect of DADLE is probably DOR-independent. Sen et al found that DADLE upregulates NGF by acti- [26] . Our present work showed that DADLE upregulates Bcl-2 expression and exhibits anti-apoptotic effects, which are very likely mediated by DOR.
ulate gene expression in neuronal cells; thus, the role of DOR remains unclear and needs further investigation. exposure could epigenetically promote Bcl-2 expression in NaN 3 -treated neurons. Bcl-2 is an important anti-apoptosis protein and is tightly associated with cell survival regulation. Evidence has shown that downregulating Bcl-2 via siRNA leads to increased apoptotic markers and ROS levels [27] , whereas overexpressing Bcl-2 protects neurons from glutamate insult [28] and focal cerebral ischemia [9] . In our present study, we found that Bcl-2 levels were downregulated during NaN 3 exposure; this effect was reversed by the co-administration of DADLE. This change in Bcl-2 protein levels is consistent with that in mRNA levels and was inhibited by LY296004 and VIII, indicating that sustained DADLE stimulation may restore Bcl-2 protein levels mainly by attenuating its transcriptional dysfunction via PI3K/Akt signaling.
The anti-apoptotic functions of Bcl-2 are not only associated with its protein levels but also regulated by its phosphorylation. It has been suggested that in a mitotic arrest-induced model, multi-site phosphorylation of Bcl-2 within an unstructured loop inhibits its anti-apoptotic functions [29] . In contrast, the phosphorylation of Bcl-2 at S70 prevents apoptosis in cytokine-dependent cell lines [30] . Therefore, further studies are needed to determine how the phosphorylation status of Bcl-2 is affected by NaN 3 and DADLE treatment. different subunit isoforms that are ubiquitously expressed; genes, and some of these genes are involved in the process of apoptosis [31] . Several studies showed that translocation of PI3K/Akt pathway; there, it participates in regulating antiapoptotic gene expression [32, 33] , possibly through enhancing acetylation efficiency in the p65 binding region [34] . In the present study, we revealed that DOR stimulation reversed NaN 3 -induced p65 inhibition via the PI3K/Akt pathway and promoted Bcl-2 transcription by increasing the histone acetylation of the Bcl-2 promoter. These results are supported to the Bcl-2 promoter and promote its transcription [35, 36] , as well as the fact that sustained DOR activation enhanced p65 binding to the Bcl-2 promoter in neurons treated with NaN 3 in this study. Therefore, upon sustained DADLE stimulation in NaN 3 -induced mitochondrial injury, the epigenetic upregulation of Bcl-2 expression might play an important role in the downstream signaling of DOR neuroprotection. Since Bcl-2 levels could be affected by both the expression and degradation processes, whether NaN 3 or DADLE affect Bcl-2 protein degradation still needs further investigation.
In conclusion, we showed here that the mechanism underlying sustained DOR activation by DADLE is very different from the mechanism underlying its short-term stimulation in NaN 3 -treated neurons. A different signaling pathway (PI3K/ -sion through epigenetic regulation. Bcl-2 upregulation suppresses Cyto c release and rescues neuronal cells (Figure 6 ). The present work is an essential supplement to our earlier studies and implies that DADLE may provide a distinct therapeutic opportunity for stroke treatment.
